News
In a Phase Ia trial in ovarian cancer, a strong neutralizing antibody response correlated with better disease control and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback